Blood biomarkers of inflammation and brain-derived neurotrophic factor can not be used to assess the effectiveness of collagen mesotherapy in chronic cervical myofascial pain syndrome. A pilot single-blind randomized study.

Saved in:
Bibliographic Details
Title: Blood biomarkers of inflammation and brain-derived neurotrophic factor can not be used to assess the effectiveness of collagen mesotherapy in chronic cervical myofascial pain syndrome. A pilot single-blind randomized study.
Authors: Koszela K; Department of Musculoskeletal Disorders, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland. kamil.aikido@interia.pl., Paradowska-Gorycka A; Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Kwiatkowska B; Early Arthritis Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Woldańska-Okońska M; Department of Internal Medicine, Rehabilitation and Physical Medicine, Medical University of Lodz, Łódź, Poland., Stypińska B; Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Ejma-Multański A; Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Gasik R; Department of Neuroorthopedics and Neurology Clinic and Polyclinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
Source: Rheumatology international [Rheumatol Int] 2026 Mar 02; Vol. 46 (3). Date of Electronic Publication: 2026 Mar 02.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Electronic Cited Medium: Internet ISSN: 1437-160X (Electronic) Linking ISSN: 01728172 NLM ISO Abbreviation: Rheumatol Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first